Indonesian Foreign Policy on Covid-19 Vaccine Procurement

Main Article Content

Deasy Silvya Sari Mas Halimah Mas Halimah Akim Akim Ali Zahid Habibullah

Abstract

This study aimed to explain Indonesia's foreign policy on Covid-19 vaccine procurement. It applied foreign policy concepts and qualitative methods to direct, collect, and analyze data. The data were collected through focus group discussions and structured interviews. The results showed that Indonesia's foreign policy on Covid-19 management had a national interest in protecting the public from contracting the virus. The country had 10 vaccines, including Sinovac, AstraZeneca, Pfizer, Moderna, Sinopharm, Johnson & Johnson, Sputnik V, CanSino, Novavax, and Zifivax. The procurement of the Covid-19 vaccine is carried out through bilateral and multilateral channels. The vaccine procurement financing was through buying and grants. The granting countries included China, Japan, the Netherlands, the United States, and the United Arab Emirates; while Covax Facility provided the multilateral grant.

Article Details

How to Cite
SARI, Deasy Silvya et al. Indonesian Foreign Policy on Covid-19 Vaccine Procurement. Intermestic: Journal of International Studies, [S.l.], v. 7, n. 1, p. 277-297, nov. 2022. ISSN 2503-443X. Available at: <https://intermestic.unpad.ac.id/index.php/intermestic/article/view/488>. Date accessed: 27 feb. 2024. doi: http://dx.doi.org/10.24198/intermestic.v7n1.13.
Section
Research Article